1. Åblad, B., Johnsson, G., Norrby, A., Sölvell, L.: Potency and time effect relationship in man of propranolol and H 56/28-comparative studies after oral administration. Acta pharmacol. (Kbh.)25 (Suppl. 2), 85 - 94 (1967)
2. Åblad, B., Ervik, M., Hallgren, J., Johnsson, G., Sölvell, L.: Pharmacological effects and serum levels of orally administered alprenolol in man. Europ. J. clin. Pharmacol.5, 44 - 52 (1972)
3. Åblad, B., Borg, K.O., Johnsson, G., Regårdh, C.G., Sölvell, L.: Combined pharmacokinetic and pharmacodynamic studies on alprenolol and 4-hydroxyalprenolol in man. Life Sci.14, 693 - 704 (1974)
4. von Bahr, C., Alván, G., Lind, M., Mellström, B., Sjöqvist, F.: ?First-pass? effect and dose dependent availability as factors contributing to interindividual differences in equilibrium concentrations of alprenolol in man. Abstract. Int. Congress of Pharmacy, Stockholm 1974
5. Bodén, N.-O.: Identification of the major urinary metabolite of alprenolol in man, dog and rat. Life Sci.14, 685 - 692 (1974)